Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:BACK

IMAC Q3 2024 Earnings Results & Report

IMAC logo
$0.0005 0.00 (0.00%)
As of 10/23/2026

IMAC reported Q3 2024 earnings on January 17, 2025. The company reported EPS of -$1.33.

Earnings Announcement Details

Quarter
Q3 2024
Report Date
Time
After Market Closes

IMAC EPS Results

Actual EPS
-$1.33
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 4 quarters

IMAC Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

IMAC's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

IMAC Q3 2024 Earnings FAQ

IMAC (NASDAQ:BACK) reported earnings of -$1.33 per share for Q3 2024. The report was announced on Friday, January 17, 2025.

IMAC's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for IMAC on the company's earnings history page.

IMAC Earnings Headlines

Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.tc pixel
See More IMAC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IMAC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IMAC and other key companies, straight to your email.

About IMAC

IMAC (NASDAQ:BACK) was a healthcare company that operated outpatient medical centers under the IMAC Regeneration Centers brand. The company focused on non-surgical treatment and rehabilitation for musculoskeletal conditions, including sports injuries, back and neck pain, joint problems, and other orthopedic issues.

Its services included regenerative medicine consultations and procedures, physical therapy, chiropractic care, sports medicine, and other rehabilitation services. IMAC’s business model combined physician-led care with therapy and wellness services intended to help patients manage pain, improve mobility, and recover from injury.

The company historically served patients through centers in parts of the United States, including markets in the Midwest and South. IMAC Holdings traded on the Nasdaq under the symbol BACK. Publicly available information about its later operations and leadership is limited, so additional current company details cannot be stated reliably.

View IMAC Profile